RT Journal Article SR Electronic T1 Prevention of cardiovascular disease and renal failure in type 2 diabetes: sodium-glucose cotransporter-2 (SGLT2) inhibitors JF BMJ Evidence-Based Medicine JO BMJ EBM FD BMJ Publishing Group Ltd SP bmjebm-2019-111231 DO 10.1136/bmjebm-2019-111231 A1 Jack W O’Sullivan YR 2019 UL http://ebm.bmj.com/content/early/2019/09/05/bmjebm-2019-111231.abstract AB